1. Lorenzo-Betancor, Oswaldo, Blackburn, Patrick R, Edwards, Emily, Meschia, James, Ross, Owen A. 2018. PCNT point mutations and familial intracranial aneurysms. In Neurology, 91, e2170-e2181. doi:10.1212/WNL.0000000000006614. https://pubmed.ncbi.nlm.nih.gov/30413633/
2. Wang, Xuyang, Yang, Jinran, Luo, Laibang, Li, Xinchang, Zhang, Youfu. 2023. PCNT is a prognostic biomarker correlated with tumor immune microenvironment in hepatocellular carcinoma and promotes tumor progression by inhibiting cell cycle arrest. In Aging, 15, 4122-4143. doi:10.18632/aging.204711. https://pubmed.ncbi.nlm.nih.gov/37211383/
3. Waich, Stephanie, Janecke, Andreas R, Parson, Walther, Valovka, Taras, Vodopiutz, Julia. 2020. Novel PCNT variants in MOPDII with attenuated growth restriction and pachygyria. In Clinical genetics, 98, 282-287. doi:10.1111/cge.13797. https://pubmed.ncbi.nlm.nih.gov/32557621/
4. Petraroli, Maddalena, Percesepe, Antonio, Piane, Maria, Esposito, Susanna Maria Roberta, Street, Maria Elisabeth. 2023. Case Report: short stature, kidney anomalies, and cerebral aneurysms in a novel homozygous mutation in the PCNT gene associated with microcephalic osteodysplastic primordial dwarfism type II. In Frontiers in endocrinology, 14, 1018441. doi:10.3389/fendo.2023.1018441. https://pubmed.ncbi.nlm.nih.gov/37234811/